Patents Assigned to Taizhou EOC Pharma Co., Ltd.
  • COMPOUND OF EOC315 MOD.I CRYSTAL FORM AND PREPARATION METHOD THEREOF
    Publication number: 20210171536
    Abstract: The present application relates to a crystalline form of 4-(4-chloroanilino)-7-(2-methylaminocarbonyl-4-oxymethyl)pyridylfuro[2,3-d]pyridazine mesylate (EOC315) that contains crystalline form Mod. I. The present application also relates to a process for the preparation of the crystalline form and the pharmaceutical use of the crystalline form.
    Type: Application
    Filed: February 19, 2021
    Publication date: June 10, 2021
    Applicant: Taizhou EOC Pharma Co., Ltd.
    Inventors: Heting LI, Deqiang WANG, Wei CHANG, Hongrui YU, Xiaoming ZOU
  • Compound of EOC315 Mod.I crystal form and preparation method thereof
    Patent number: 10954246
    Abstract: A crystalline form of Mod. I of Formula I: And, a process for the preparation of the crystalline form and a pharmaceutical use of the crystalline form.
    Type: Grant
    Filed: October 11, 2019
    Date of Patent: March 23, 2021
    Assignee: Taizhou EOC Pharma Co., Ltd.
    Inventors: Heting Li, Deqiang Wang, Wei Chang, Hongrui Yu, Xiaoming Zou
  • COMPOUND OF EOC315 MOD.I CRYSTAL FORM AND PREPARATION METHOD THEREOF
    Publication number: 20200071336
    Abstract: The present application relates to a crystalline form of 4-(4-chloroanilino)-7-(2-methylaminocarbonyl-4-oxymethyl)pyridylfuro[2,3-d]pyridazine mesylate (EOC315) that contains crystalline form Mod. I. The present application also relates to a process for the preparation of the crystalline form and the pharmaceutical use of the crystalline form.
    Type: Application
    Filed: October 11, 2019
    Publication date: March 5, 2020
    Applicant: Taizhou EOC Pharma Co., Ltd.
    Inventors: Heting LI, Deqiang WANG, Wei CHANG, Hongrui YU, Xiaoming ZOU